Coffee Chat: Meg Rand, Acosta Group
GLP-1 users drive trends across range of product segments.
GLP-1s
GLP-1 ‘halo effect’ reshapes consumer behavior
New Acosta Group research shows GLP-1 users are driving shifts toward healthier eating, targeted wellness and new retail opportunities.
Walmart expands weight management support for GLP‑1 users
Walmart is expanding its Better Care Services platform.
Kroger pharmacies add Zepbound KwikPen as GLP-1 access expands
“Our customers and communities want affordable, effective weight-management treatment options with real affordability,” said Colleen Lindholz, group vice president and president of Kroger Health.
ShopRite launches GLP-1 Wellness Your Way Starter Kits
Customers filling their first GLP1 prescription at a ShopRite Pharmacy will receive a complimentary kit while supplies last.
Amazon Pharmacy broadens Wegovy pill access via insurance and cash option
Eligible customers with commercial insurance may pay as little as $25 for a one-month supply.
Sam’s Club rolls out pharmacist-led support as oral GLP-1 option launches
Sam’s Club pharmacies have been ranked No. 1 in customer satisfaction among mass merchandiser pharmacies by J.D. Power for 10 consecutive years.
retailmediaIQ + NIQ + Think Blue: Re-imagining Women’s Wellness webinar
Save the Date: Tuesday, November 25, 2:00 p.m. ET.
Walmart, Eli Lilly partner to expand direct-to-consumer Zepbound pricing
Walmart will serve as the first in-store pickup pharmacy for LillyDirect’s self-pay single-dose vials.
Sam’s Club adds same-day refrigerated prescription delivery
The new service underscores the club’s growing role in retail healthcare and its competitive value for Plus Members.
Costco Pharmacy to offer Ozempic and Wegovy for $499 a month
Costco is leveraging its scale and membership model to compete in a growing consumer health segment.
Richer milk, greater retail impact
What dairy’s shifting composition means for retailers riding the protein wave.
Protein trend reshapes grocery aisles
Retailers can leverage the protein trend to boost sales and improve their position among health-conscious consumers.
GLP-1: A weighty matter for CPG companies
Obstacles to the uptake of anti-diabetes drugs are receding as their popularity as a weight-loss remedy rises.
US employers consider cutting health benefits as the costs of weight-loss drugs rise
The rising costs tied to GLP-1 drugs are emerging as a strategic workforce issue.
GLP-1 users at risk of nutritional deficiencies, GNC study finds
The results revealed multiple diet deficiencies linked to reduced food consumption and altered habits.